Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.2. Removed Revision: v3.5.0.SummaryDifference0.1%

- Check8 days agoChange DetectedRemoved the 'Multiple Myeloma' condition label and the 'MedlinePlus Genetics' related topics from the study page.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded related topics for the study: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check30 days agoChange DetectedRevision: v3.5.0 added. The page no longer includes 'Multiple myeloma' or 'MedlinePlus Genetics' as related topics in the related topics section.SummaryDifference0.2%

- Check44 days agoChange DetectedMetadata and taxonomy updates were applied to the study page, including new date entries and related topic references (Multiple myeloma and MedlinePlus Genetics). The revision tag was updated from v3.4.2 to v3.4.3, and older revision entries were removed.SummaryDifference0.6%

- Check51 days agoChange DetectedRemoved references to Multiple Myeloma and MedlinePlus Genetics from the page.SummaryDifference0.2%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.